Expression of androgen receptor target genes in skeletal muscle

We aimed to determine the mechanisms of the anabolic actions of androgens in skeletal muscle by investigating potential androgen receptor （AR）-regulated genes in in vitro and in vivo models. The expression of the myogenic regulatory factor myogenin was significantly decreased in skeletal muscle from testosterone-treated orchidectomized male mice compared to control orchidectomized males, and was increased in muscle from male AR knockout mice that lacked DNA binding activity （AR△ZF2） versus wildtype mice, demonstrating that myogenin is repressed by the androgen/AR pathway. The ubiquitin ligase Fbxo32 was repressed by 12 h dihydrotestosterone treatment in human skeletal muscle cell myoblasts, and c-Myc expression was decreased in testosterone-treated orchidectomized male muscle compared to control orchidectomized male muscle, and increased in AR△ZF2 muscle. The expression of a group of genes that regulate the transition from myoblast proliferation to differentiation, Tceal7, p57Kip2, IEf2 and calcineurin Aa, was increased in AR△ZF2 muscle, and the expression of all but p57kip2 was also decreased in testosterone-treated orchidectomized male muscle compared to control orchidectomized male muscle. We conclude that in males, androgens act via the AR in part to promote peak muscle mass by maintaining myoblasts in the proliferative state and delaying the transition to differentiation during muscle growth and development, and by suppressing ubiquitin ligase-mediated atrophy pathways to preserve muscle mass in adult muscle.

三阴性乳腺癌组织中EGR1、AR、H3K4me3表达与其临床病理特征及预后的相关性

目的探讨三阴性乳腺癌组织中早期生长反应基因1(EGR1)、雄激素受体(AR)、组蛋白H3第4位赖氨酸三甲基化(H3K4me3)表达与其临床病理特征及预后的相关性。方法回顾性分析89例三阴性乳腺癌患者的临床资料,所有患者均行手术治疗,采用免疫组化染色法测定EGR1、AR、H3K4me3表达,比较肿瘤组织及癌旁正常组织内EGR1、AR、H3K4me3表达差异,分析EGR1、AR、H3K4me3表达与其临床病理的关系,分析EGR1、AR、H3K4me3表达与其预后的关系。结果肿瘤组织内EGR1阳性表达率、AR阳性表达率低于对照组,H3K4me3阳性表达率高于对照组,差异有统计学意义(P<0.05);EGR1阳性表达、AR阳性表达患者临床分期Ⅰ~Ⅱ期、无淋巴结转移、中高分化占比高于EGR1阴性表达、AR阴性表达患者,H3K4me3阳性表达患者临床分期Ⅲ期、淋巴结转移、低分化占比高于H3K4me3阴性表达患者,差异有统计学意义(P<0.05);随访1年,89例患者共36例出现复发转移,发生率为40.45%(36/89);复发转移组EGR1阳性表达、AR阳性表达率低于未复发转移组,H3K4me3阳性表达率高于未复发转移组,差异有统计学意义(P<0.05)。结论EGR1、AR在三阴性乳腺癌中多呈阴性表达,H3K4me3则以阳性表达为主,三者表达均与临床分期、淋巴结转移及分化程度存在密切关系,或可作为临床治疗的新靶点。

Novel mutation in the ligand-binding domain of the androgen receptor gene （1790p） associated with complete androgen insensitivity syndrome

Mutations in the X-linked androgen receptor （AR） gene cause androgen insensitivity syndrome （AIS）, resulting in an impaired embryonic sex differentiation in 46,XY genetic men. Complete androgen insensitivity （CAIS） produces a female external phenotype, whereas cases with partial androgen insensitivity （PALS） have various ambiguities of the genitalia. Mild androgen insensitivity （MAIS） is characterized by undermasculinization and gynecomastia. Here we describe a 2-month-old 46,XY female patient, with all of the characteristics of CAIS. Defects in testosterone （T） and dihydrotestosterone （DHT） synthesis were excluded. Sequencing of the AR gene showed the presence in exon 6 of a T to C transition in the second base of codon 790, nucleotide position 2369, causing a novel missense Leu790Pro mutation in the ligand-binding domain of the AR protein. The identification of a novel AR mutation in a girl with CAIS provides significant information due to the importance of missense mutations in the ligand-binding domain of the AR, which are able to induce functional abnormalities in the androgen binding capability, stabilization of active conformation, or interaction with coactivators.

Androgen receptor gene polymorphism and sex hormones in elderly men:the Tromsøstudy

The aim of this study was to examine whether CAG/GGN repeats are significant modulators of serum concentrations of total and free testosterone(T)as well as of luteinizing hormone(LH)in elderly men.Sixty-nine 60-to 80-year-old men with subnormal T levels(≤11.0 nmol L^(-1))and 104 men with normal T levels taking part in a nested case-control study were used for these analyses.Sex hormones were measured and free T was calculated.The CAG and GGN polymorphisms in the androgen receptor gene were determined by polymerase chain reaction and subsequent direct sequencing.There were no differences in the CAG and GGN repeat lengths between the groups.In cross-sectional analyses of the whole cohort,total and free T were positively associated with CAG length(all P<0.05)before,but not after,waist circumference or body mass index was added to the model.CAG repeat lengths were weakly,but not independently,associated with total and free T.These findings indicate that when clinically evaluating T and LH levels in elderly men,the CAG and GGN repeat lengths do not need to be taken into consideration.

Correlation study between the polymorphism of repetitive sequence in gene CAG of androgen receptor and the occurrence and progression of prostate cancer

Objective:To explore the relation between the polymorphism of repetitive sequence in gene CAG of androgen receptor(AR)and the susceptibility and clinical stages as well as pathological grading of prostate cancer among Han population.Method:Sixty-eight cases with prostate cancer hospitalized in Urinary Surgery Department from Feb.2010 to Feb.2012 and 60 healthy cases were chosen as research subjects.Methods of PCR and direct sequencing were adopted to detect DNA sequence of AR gene and the length of repetitive sequence in CAG.Results:The lengths of repetitive sequence in CAG of patients with prostate cancer and healthy people were(22.3±4.6)and(23.0±4.9),respectively showing no statistical significance.Comparing length(repetitive sequence of CAG)>22,those with that<22 suffer a remarkably higher risk of prostate cancer(P<0.05).The number of repetitive sequence in CAG of patients at clinical stage C-D was less than that of patients at stage B,and the number of repetitive sequence in CAG of patients with poorly differentiated prostate cancer was also less than that of patients with moderately and highly differentiated prostate cancer.But there was no statistical significance int the difference(P>0.05);the proportion of patients with length<22 at clinical stage C-D was much larger than that of patients at clinical stage B(P<0.05),and as the aggravation of pathological grading,the proportion of patients with the length<22 was also remarkably increased and there was significant difference between patients with highly differentiated prostate cancer and those with poorly differentiated prostate cancer(P<0.05).Conclusions:There is correlation between the occurrence and development of prostate cancer in Han population and the polymorphism of repetitive sequence in gene CAG of androgen receptor.The less the number of repetitive sequence in CAG is,the higher the risk of prostate cancer will be and the more severe the clinical stage and pathological grading will be.

Therapeutic targeting of the androgen receptor(AR)and AR variants in prostate cancer

Prostate cancer(PCa)accounted for over 300000 deaths world-wide in 2018.Most of the PCa deaths occurred due to the aggressive castration-resistant PCa(CRPC).Since the androgen receptor(AR)and its ligands contribute to the continued growth of androgendependent PCa(ADPCa)and CRPC,AR has become a well-characterized and pivotal therapeutic-target.Although AR signaling was identified as therapeutic-target in PCa over five-decades ago,there remains several practical issues such as lack of antagonist-bound AR crystal structure,stabilization of the AR in the presence of agonists due to N-terminus and C-terminus interaction,unfavorable large-molecule accommodation of the ligand-binding domain(LBD),and generation of AR splice variants that lack the LBD that impede the discovery of highly potent fail-safe drugs.This review summarizes the AR-signaling pathway targeted therapeutics currently used in PCa and the approaches that could be used in future ARtargeted drug development of potent next-generation molecules.The review also outlines the discovery of molecules that bind to domains other than the LBD and those that inhibit both the full length and splice variant of ARs.

Complete androgen insensitivity syndrome caused by the c.2678C>T mutation in the androgen receptor gene:A case report

BACKGROUND Androgen insensitivity syndrome is an X-linked recessive genetic disease caused by mutations in the androgen receptor gene(AR).However,the underlying molecular mechanisms for the majority of AR variants remain unclear.In this study,we identified a point variant in three patients with complete androgen insensitivity syndrome(CAIS),summarized the correlation analysis,and performed a literature review.CASE SUMMARY The proband was raised as a girl.In infancy,she was first referred to hospital with a right inguinal hernia.Ultrasonography revealed the absence of a uterus and ovaries,and a testis-like structure located at the inguinal canal.Further diagnostic workup detected a 46,XY karyotype,and fluorescence in situ hybridization analysis showed the presence of the SRY gene.Histological analysis revealed the excised tissue to be testicular.Twelve years later,she was admitted to our hospital with a lack of breast development.Her pubic hair and breasts were Tanner stage I.She had normal female external genitalia.Blood hormone tests showed normal testosterone levels,low estradiol levels,and high gonadotropin levels.Her two siblings underwent similar examinations,and all three had a rare hemizygous missense mutation in AR:c.2678C>T.In vitro functional analyses revealed decreased nuclear translocation in AR-c.2678C>T mutation cells.CONCLUSION This case of CAIS was caused by an AR variant(c.2678C>T).Functional studies showed impaired nuclear translocation ability of the mutant protein.

Mating behavior induces changes of expression of Fos protein,plasma testosterone and androgen receptors in the accessory olfactory bulb (AOB) of the male mandarin vole Microtus mandarinus

In order to investigate the neuroendocrine mechanism of the mating behavior in the adult male mandarin voles Microtus mandarinus,the radioimmunoassay(RIA)and immunohistochemistry methods were used to investigate the differences in plasma testosterone(T)concentrations and distribution of T immunoreactive neurons(T-IRs),androgen receptor immunoreactive neurons(AR-IRs)and Fos protein immunoreactive neurons(Fos-IRs)in the accessory olfactory bulb(AOB)and the main olfactory bulb(MOB)following exposure to clean hard-wood shavings(control group),soiled bedding(exposure group)or contact with an estrous female(mating group).Results showed that plasma T concentration was significantly higher in the mating group than that in the exposure group,and both the mating group and the exposure group displayed significantly higher plasma T concentration than the control group.T-IRs,AR-IRs and Fos-IRs were investigated with the immunohistochemistry method in granule cell(GC)and mitral cell(MC)of the MOB and the AOB in the three groups.There were significantly more T-IRs,AR-IRs and Fos-IRs in MC and GC of the AOB in the mating group than that in the exposure group or the control group.T-IRs,AR-IRs and Fos-IRs did not show significant differences between the exposure group and the control group.Furthermore,obvious differences in MC and GC of the MOB were not found among the three groups.The results confirm that both changes of T and AR in the AOB might be underlying mating behavior in the adult male mandarin voles.

Mutations in the androgen receptor gene of seven Chinese patients with complete androgen insensitivity syndromes

To further investigate the molecular mechanism of androgen insensitivity syndromes (AIS), exons B to H of the androgen receptor (AR) gene in seven Chinese patients with Complete AlS (CAIS) were examined by the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis and direct DNA sequencing. Four distinct point mutations (Gly743Arg, Va1866Met, Arg752Gln, T2919→deletion) were identified in 4patients, and all the mutations were localized in exons E or G encoding androgen binding domain of AR. The frame-shift mutation caused by deletion of T2919 had not been reported yet so far, therefore, It was a novel mutation. Detection of the AR gene in 2 mothers showed both of them were heterozygotes carrying the same mutationsas their daughters. our study was helpful for further delineating the diversity of genetic alterations of the AR gene in patients with AlS and better understanding the relationships between structure and function of AR.

Suppression of androgen receptor gene expression by testosterone undecanoate in rats

The mechanism of antifertility effect of testosterone undecanoate on male rat was investigated. Eight 12-week old rats were injected with 20 mg/kg of testosterone undecanoate at bi--week intervals for 3 months. As compared to that in the 10 control rafs, the sperm density in testis rete fluid of the treatment rats declined by 7%, the motility of sperm from epididymis cauda reduced to 6%. While the testosterone level in serum increased to 255 %, the testosterone level in testis rete fluid decreased to 55%. All of these differences were significant. The androgen receptor gene expression in the testis and epididymis was suppressed in the treatment group. The decrease in output of the sperm and sperm motility of epididymis cauda may be due to the reduced testosterone production by Leydig cells and suppression of androgen receptor gene expression in testis and epididymis.

Prostate androgen-regulated gene:a novel potential target for androgen-independent prostate cancer therapy

Aim:To investigate the involvement of the prostate androgen-regulated(PAR)gene in the androgen receptor(AR) signaling pathway and the malignant phenotype of androgen-independent prostate cancer(PCa)cells.Methods:The difference in PAR expression between LNCaP and PC3 cells was detected by reverse transcription-polymerase chain reaction(RT-PCR).Androgen and anti-androgen effects on PAR expression were evaluated by RT-PCR in LNCaP,PC3 cells and PC3 cells stably transfected with vector containing wild-type AR.To determine the importance of PAR in the malignant proliferation of androgen-independent PCa cells,we used small interfering RNA(siRNA)transfection to knock down the expression of the gene in PC3 cells.The changes in the malignant phenotype of PCa cells after transfection were analyzed by cell count,colony formation in soft agar and flow cytometry.Results:PAR expression was 3-fold higher in PC3 cells than that in LNCaP cells.Dihydrotestosterone(DHT)regulated PAR mRNA expression in LNCaP cells and the effect was inhibited by the AR antagonist,flutamide.By contrast,DHT did not affect PAR expression in PC3 cells.The reintroduction of AR into PC3 cells by stable transfection restored the androgen effect on PAR upregulation. After the knockdown of the PAR gene by siRNA,PC3 cells exhibited a reversal of the malignant phenotype.Conclusion: Because of the possibility that PAR is downstream from the AR,and because of its contribution to malignant proliferation in androgen-independent PCa cells,the gene could be a potential therapeutic target for androgen-independent PCa with AR signaling pathway alteration.(Asian J Andro12006 Jul;8:455-462)

The effect of diet-induced insulin resistance on DNA methylation of the androgen receptor promoter in the penile cavernosal smooth muscle of mice

Population studies have suggested an association between diabetes and the symptoms of testosterone deficiency. Recently, the expression of the androgen receptor （AR） has been shown to be decreased in diabetic patients. Furthermore, diabetes has been shown to induce global methylation. In this study, we used an animal model to investigate whether diabetes results in increased methylation of the AR promoter and whether these changes are associated with the decreased expression of AR in penile cavernosal smooth muscle tissue. Twenty C57BL/6J mice were divided into two groups, receiving either high- （mature diabetic） or low- （mature control） caloric meals for 14 weeks. Another 10 mice were killed at 1 week （young control）. Animals in the mature diabetic group showed decreased testosterone levels, although this was not statistically significant. In both control groups, no significant methylation was observed in the AR promoter region CpG island （-85 to ＋339）. In the mature diabetic group, significant methylation was observed at ＋ 185 and ＋200 of the AR promoter. These changes were associated with increased homeostatic model assessment for insulin resistance （HOMA-IR） and decreased corpus cavernosal tissue mass and expression of AR mRNA and protein. We conclude that in these animals, insulin resistance increased the methylation of the GC-rich regions of the AR promoter, leading to decreased AR expression.

The relationship between anogenital distance and the androgen receptor CAG repeat length

Anogenital distance （AGD） is used to define degree of virilization of genital development, with shorter length being associated with feminization and male infertility. The first exon of the androgen receptor （AR） consists of a polymorphic sequence of cytosine-adenineguanine （CAG） repeats, with longer CAG repeat lengths being associated with decreased receptor function. We sought to determine if there is an association between AGD and AR CAG repeat length. A cross-sectional, prospective cohort of men evaluated at a urology clinic at a single institution was recruited. AGD （the distance from the posterior scrotum to the anal verge） and penile length （PL） were measured. Sanger DNA sequence analysis was used to define CAG repeat length. AGD and CAG repeat lengths in 195 men were determined. On unadjusted analysis, there was no linear relationship between CAG repeat length and PL （P=0.17） or AGD （P=-0.31）. However, on sub-population analyses, those men with longer CAG repeat lengths （〉26） had significantly shorter AGDs compared to men with shorter CAG repeat lengths. For example, the mean AGD was 41.9 vs. 32.4 mm with a CAG repeat length ≤26 vs. 〉26 （P=0.01）. In addition, when stratifying the cohort based on AGD, those with AGD less than the median （i.e. 40 mm） had a longer CAG repeat length compared to men with an AGD 〉40 mm （P=-0.02）. In summary, no linear relationship was found between AGD and AR CAG repeat length overall.

A protein in rat prostatic interacting with androgen regulated gene

2M NaCl-insoluble fraction of rat ventral prostatechromatin(residual proteins)contain proteins able tointeract specifically with androgen-receptor complex andis,therefore,a part of the acceptor complex.Amongresidual proteins,a 97 KDa protein has been found whichbinds signifieantly to a genomic fragment containingan androgen-regulated gene coding for a 22 KDa protein.The biological significance of this binding in androgenaction need to be further studied. A mini-plasmid clone containing 22 KDa proteincoding sequence was cloned into Charon 4A genomiclibrary from which a 5.7 Kb genomic fragment wasisolated,identified by hybridization with a 5’ and a 3’cDNA probes,and shown to contain the 5’ flankingsequence.Restriction enzyme treatment of this fragmentyielded a 4.7 Kb restriction fragment representingthe 5’ upstream region and a 1.0 Kb containing part ofthe coding sequence.Deletion studies indicated that the97 KDa protein bound only to a subclone of about 300 bpsegment.Furthermore,gel shifting experiment supportedits DNA-prptein binding.

4例46,XY性发育障碍患者遗传学分析

目的:探讨4例46,XY性发育障碍发生的分子机制。方法:收集患者临床病历资料,采集其肝素抗凝外周血进行淋巴细胞培养,染色体G显带技术制备并分析染色体核型,提取外周血DNA行SRY基因检测和测序,SRY基因检测结果阴性者外送标本行性发育相关基因靶向测序,生物信息学方法分析测序结果。结果:查体显示4例患者社会性别均为女性,而外周血淋巴细胞核型分析结果提示核型均为男性(46,XY),社会性别与生物学性别不一致;性别决定基因SRY均为阳性,测序结果提示病例1为SRY基因编码区第5位碱基缺失(c.del5A),病例2为SRY基因编码区第5位碱基发生错义突变(c.5A>T),病例3为SRY基因编码区第6位碱基缺失(c.del6A),病例4的SRY基因检测范围内未见突变位点,靶向测序结果提示雄激素受体基因(AR)编码区发生错义突变(c.2117 A>G);生物信息学软件Mutation taster提示c.del5A、c.del6A和c.2117 A>G等3种突变可能导致疾病发生,c.5A>T突变可能为人群多态现象;Raptor X蛋白质三维结构预测软件分析结果显示SRY基因c.5A>T突变对SRY蛋白的三维构象没有影响,而AR基因c.2117 A>G突变可导致AR蛋白的三维结构明显变化,并增加两个氢键;PolyPhen-2显示SRY基因c.5A>T和AR基因c.2117A>G突变为可能致病;ClinvAR软件分析结果提示4种突变均未见临床病例报道。结论:基因突变可能是导致患者性器官发育异常的原因,基因检测有助于明确诊断以及家庭再生育咨询。

9例儿童雄激素不敏感综合征临床特点和遗传学特点分析

目的 分析雄激素不敏感综合征(androgen insensitivity syndrome, AIS)患者的临床资料和遗传学结果。方法 收集2017—2022年在江西省儿童医院就诊的9例AIS患者临床资料,完善相关实验室检查及性腺、腹股沟彩超,并进行基因突变检测。结果 9例患者染色体均为男性核型,其中7例患者的社会性别为女性,2例为男性;所有患者就诊原因均有腹股沟斜疝(或伴有性别模糊),均发现AR基因突变,病例1为新突变(p.R608fs*18)。66.6%(6/9)的AIS患者突变位于配体结合域(ligand binding domain, LDB),80%(4/5)的完全型雄激素不敏感综合征患者突变位于LBD,50.0%(2/4)的部分型雄激素不敏感综合征患者突变位于LBD。55.5%(5/9)AIS患者突变类型为错义突变。结论 错义突变为AR基因常见突变类型,LBD是AIS的主要突变部位,外生殖器表现为女性患者,如发现腹股沟斜疝,应常规行性腺及腹股沟彩超检查以排外AIS。

神经胶质细胞系衍生神经营养因子和雄激素受体在手术诱导隐睾小鼠睾丸管周细胞中的表达

【目的】探讨神经胶质细胞系衍生神经营养因子(GDNF)和雄激素受体(AR)在隐睾症小鼠睾丸管周细胞中的表达水平及对隐睾症导致生精功能障碍的理论意义。【方法】30只5周龄雄性ICR小鼠采用随机数字表法随机分配至6组中,随机抽取3组15只小鼠进行手术诱导隐睾,其余3组为作为对照组进行假手术处理。分别于4 d、7 d、14 d后取各组睾丸组织,然后测量睾丸体积、观察睾丸组织病理,提取各组睾丸管周细胞后利用免疫荧光、Re⁃al-Time PCR和蛋白质印记法检测AR和GDNF的mRNA和蛋白的表达。【结果】对照组4 d、7 d、14 d小鼠的睾丸体积分别为(125.58±19.22)mm^(3)、(123.45±20.12)mm^(3)、(140.09±13.62)mm^(3);睾丸各级生精细胞排列整齐、层次清楚,可见较多精子细胞,生精小管周围管周细胞形态规则,呈梭形围绕小管周围,细胞厚度均一;ARmRNA的表达量分别为1.00±0.05、1.06±0.07、1.19±0.13GDNFmRNA的表达量分别为1.00±0.04、1.09±0.05、1.10±0.07;AR蛋白的表达量分别为1.01±0.01、0.79±0.02、1.01±0.04;GDNF蛋白的浓度分别为(18.68±0.43)pg/mL、(14.39±0.36)pg/mL、(16.88±0.37)pg/mL。隐睾组4 d、7 d、14 d小鼠的睾丸体积分别为(115.64±3.91)mm^(3)、(69.51±14.97)mm^(3)、(44.86±5.56)mm^(3);睾丸各级生精细胞排列紊乱、层次不清、结构破坏,曲细精管周围管周细胞萎缩、弯曲断裂;ARmRNA的表达量分别为0.76±0.06、0.53±0.04、0.29±0.02;GDNFmRNA的表达量分别为0.72±0.05、0.42±0.02、0.30±0.03;AR蛋白的表达量分别为0.54±0.02、0.98±0.04、0.31±0.01;GDNF蛋白的浓度分别为(8.50±0.34)pg/mL、(17.44±0.32)pg/mL、(6.83±0.34)pg/mL。上述指标与对照组相比,除了4 d的睾丸体积差异无统计学意义(P>0.05),其他均有统计学差异(P<0.05)。对照组中3个时间点的睾丸体积、AR和GDNF的mRNA、蛋白表达量的差异无统计学意义(P>0.05),隐睾组3个时间点的睾丸体积、AR和GDNF的mRNA、蛋白表达量呈逐渐下降趋势且各组之间的差异均有统计学意义(P<0.05)。【结论】在手术诱导隐睾小鼠中,睾丸管周细胞的AR和GDNF的表达水平随着诱导时间的延长呈现显著下降。AR和GDNF在隐睾症介导睾丸管周细胞功能的损伤中有重要作用。本研究为阐明隐睾症导致生精功能障碍的机制研究提供理论基础。

完全性雄激素不敏感综合征合并苗勒管残留临床特点的分析与探讨

【目的】分析完全性雄激素不敏感综合征(CAIS)合并苗勒管残留(MDR)患儿资料,并综述既往文献的报告,提高对CAIS的临床表现、病理生理的再认识。【方法】本研究通过对患儿病史回顾,体格检查,染色体、全外显子基因测序、促卵巢刺激素、黄体生成素、总睾酮、雌二醇、抗苗勒管激素、抑制素B、硫酸脱氢表雄酮、雄烯二酮、17羟孕酮等实验室检查,以及盆腔彩超、盆腔磁共振等影像学检查来诊断完全性雄激素不敏感综合征,并在腹腔镜下发现苗勒管结构。同时总结分析既往文献报道的完全性雄激素不敏感合并苗勒管结构类似病例。【结果】该患儿临床表现为女性表型,以原发性闭经来就诊,卵泡刺激素(FSH)、黄体生成素(LH)、睾酮升高,盆腔MRI示双侧隐睾,未见子宫附件,染色体核型46,XY,全外显子基因检测:AR基因半合子致病性变异c.2359C>T(p.Arg787*),AMH、AMHR2基因检测无异常。在腹腔镜下腹腔探查时发现发育不良睾丸及发育不良子宫。病理提示睾丸旁存在输卵管样结构。在数据库中共检索到基因确诊为CAIS并存MDR,且有详实数据的病例共11例。总结发现合并MDR的首诊表现、生化资料、性腺病理与无MDR的CAIS患者类似。【结论】本研究报道的CAIS患儿合并MDR,拓宽了CAIS的临床表现谱,为苗勒管退化的基础研究提供一种非依赖于AMH-AMHR2信号调控的思路。

中国北方汉族人群AR基因(CAG)n多态性与跑节省化的关联性研究

目的探讨AR基因外显子1(CAG)n重复多态性在中国北方汉族男性群体的分布特征以及其与跑节省化初始值及训练敏感性的关联性。方法对101名无训练史的健康男子进行18 w的耐力训练,测定训练前后12 km/h跑速下的跑节省化相关指标。GeneScan加测序的方法分析AR基因(CAG)n多态性。结果(1)中国北方汉族男性人群中AR基因(CAG)n重复多态存在15种等位基因,其中(CAG)22次重复等位基因分布频率最高,达到19%;(2)连续分割方法划分基因型,发现≤23次重复组RE的VO2初始值显著高于>23次重复组;但不同基因型的RE的训练敏感性没有显著性差异。结论AR基因(CAG)n重复多态性与跑节省化的初始值存在关联,但与训练效果无关联性。

非放标AR基因多态性分析探讨子宫平滑肌瘤的克隆性

目的 根据女性体细胞中两条 X染色体上雄激素受体 (AR)基因的限制性片段长度多态性进行非放标克隆性检测 ,以探讨子宫平滑肌瘤的克隆组成 .方法 自新鲜子宫平滑肌瘤组织中提取基因组 DNA,经 H ha 消化后 ,PCR扩增 ,变性聚丙烯酰胺凝胶电泳后银染显示单股 DNA片段长度 .结果 在检测的 5 4例子宫平滑肌瘤标本中 ,32例(5 9.3% )具有这种 AR位点的多态性 ;其中 3例标本 X染色体失活发生了严重偏移 ,不适用于这种克隆性分析 .对 2 9例共 6 8个平滑肌瘤结节的分析均显示 AR位点长度多态性丢失 ,提示全部为单克隆细胞组成 .其中 8例结节个数≥ 3个的多发性子宫平滑肌瘤中 ,6例标本的不同瘤结节均具有相同的 X染色体灭活带型 ;另外 ,发现 1例具有 X染色体失活偏移的标本其肿瘤组织中有额外条带出现 ,而且两个瘤结节具有相同改变 .结论 此研究为在国内开展非放标 AR克隆性检测奠定了基础 ,同时还证实我们以前的研究结果 。